2020 American Transplant Congress
Humanized Mouse Reveals the Cytoprotective Function of Hepatocyte RXFP1 in Liver Transplant Recipients
*Purpose: RXFP1 (RLX family peptide receptor 1) is a cognate receptor for relaxin (RLX), an insulin-like growth factor, with vasoactive/remodeling properties. We have documented cytoprotective…2020 American Transplant Congress
Machine Learning to Predict Deceased Donor Liver Biopsy Results
United Network for Organ Sharing, Richmond, VA
*Purpose: Biopsies are often cited as a key factor on whether to accept a deceased liver offer. Motivated by the influential role of biopsy findings…2020 American Transplant Congress
Effect of Pre-Transplant Opioid Use on Post Liver Transplant Outcomes
Lahey Hospital and Medical Center, Burlington, MA
*Purpose: Impact of pre-liver transplant opioid use on post-liver transplant length of stay and clinical outcomes.*Methods: This single-institution retrospective study included adult patients who received…2020 American Transplant Congress
An Early Look at the National Liver Review Board
*Purpose: On May 14, 2019, the National Liver Review Board (NLRB) was implemented, establishing a national structure for liver exceptions comprised of three specialty review…2020 American Transplant Congress
Hepatic Microenvironment: Molecular and Chemical Changes Associated with Preconditioning Maneuvers
*Purpose: Liver preconditioning has been described to protect liver from ischemia injury and trigger liver regeneration. Hereby, we aimed to assess the effect of preconditioning…2020 American Transplant Congress
National Trends in Locoregional Therapy among Liver Transplant (LT) Candidates with Hepatocellular Carcinoma (HCC) in the United States
1Stanford University, Redwood City, CA, 2University of California, San Francisco, San Francisco, CA
*Purpose: Advances in locoregional therapy (LRT) have expanded treatment options for patients with HCC. As recent policy changes in the United States (US) have lengthened…2020 American Transplant Congress
Liver Transplant Outcomes Across the Age Distribution and Interactions with County Health
*Purpose: We examined risk of graft failure and patient mortality after liver transplant (LT) across the age continuum and county Health Outcomes & Health Factors…2020 American Transplant Congress
Graft versus Host Disease in a Liver Transplant Patient
Department of Infectious Diseases, Baylor College of Medicine, Houston, TX
*Purpose: Graft versus host disease (GVHD) is a rare cause of morbidity and mortality in solid organ transplant (SOT) recipients; the estimated prevalence is 1-2%…2020 American Transplant Congress
Community Affluence Impacts Patient Survival Post Liver Transplantation
Surgery, University of Pittsburgh, Pittsburgh, PA
*Purpose: Liver transplantation is an effective treatment for patients with end stage liver disease with excellent patients and grafts long term outcomes. Many recipient disease…2020 American Transplant Congress
Impact of County Health Rankings on Nationwide Liver Transplant Outcomes
*Purpose: We examined the impact of social determinants of health (SDOH) in LT recipients’ counties of residence and their associations with long-term patient and graft…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 50
- Next Page »